E
Telo Genomics Corp. TELO.V
TSX
Recommendation
Prev Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Net Income -8.27% 7.44% 2.58% 26.78% -22.44%
Total Depreciation and Amortization -42.50% -37.50% -12.33% -6.41% 1.30%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items -- -- -278.38% -116.16% 45.86%
Change in Net Operating Assets 150.43% -35.64% 402.21% -69.06% 211.85%
Cash from Operations 15.43% 7.00% 14.58% 14.01% 2.51%
Capital Expenditure -- -- -- -- 100.00%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- -- --
Cash from Investing -- -- -- -- 100.00%
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- 100.00% -- --
Issuance of Common Stock -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -109,900.00% 99.48% -- -- 100.00%
Cash from Financing 1,661,700.00% -100.02% 2,777.25% -- 100.00%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 500.03% -546.48% 117.14% 10.68% 3.22%
Weiss Ratings